Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion
Cancer Medicine · 2023
DOI: 10.1002/cam4.6168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Kirsten Y Eom und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine at the MetroHealth System at Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Medicaid, Colorectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) is the fourth most common cancer and the second leading cause of cancer‐related death in the U.S. Despite increased CRC screening rates, they remain low among low‐income non‐older adults, including Medicaid enrollees who are more likely to be diagnosed at advanced stages.
Objectives
Given limited evidence regarding CRC screening service use among Medicaid enrollees, we examined multilevel factors associated with CRC testing among Medicaid enrollees in Pennsylvania after Medicaid expansion in 2015. Research Design Using the 2014–2019 Medicaid administrative data, we performed multivariable logistic regression models to assess factors associated with CRC testing, adjusting for enrollment length and primary care services use. Subjects We identified 15,439 adults aged 50–64 years newly enrolled through Medicaid expansion. Measures Outcome measures include receiving any CRC testing and by modality.
Results
About 32% of our study population received any CRC testing. Significant predictors for any CRC testing include being male, being Hispanic, having any chronic conditions, using primary care services ≤4 times annually, and having a higher county‐level median household income. Being 60–64 years at enrollment, using primary care services >4 times annually, and having higher county‐level unemployment rates were significantly associated with a decreased likelihood of receiving any CRC tests.
Conclusions
CRC testing rates were low among adults newly enrolled in Medicaid under the Medicaid expansion in Pennsylvania relative to adults with high income. We observed different sets of significant factors associated with CRC testing by modality. Our findings underscore the urgency to tailor strategies by patients' racial, geographic, and clinical conditions for CRC screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine at the MetroHealth System at Case Western Reserve University, Cleveland, Ohio, USA.
- Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Health Policy & Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA.
- Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Kirsten Y Eom, Marian P Jarlenski, Evan S Cole, Lindsay M Sabik
Zitieren
APA
Eom, K. Y., Rothenberger, S. D., Jarlenski, M. P., Schoen, R. E., Cole, E. S., & Sabik, L. M. (2023). Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion. Cancer Medicine. https://doi.org/10.1002/cam4.6168
Vancouver
Eom KY, Rothenberger SD, Jarlenski MP, Schoen RE, Cole ES, Sabik LM. Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion. Cancer Medicine. 2023. doi:10.1002/cam4.6168
BibTeX
@article{Eom2023,
author = {Eom, Kirsten Y and Rothenberger, Scott D and Jarlenski, Marian P and Schoen, Robert E and Cole, Evan S and Sabik, Lindsay M},
title = {Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6168}
}
EUVIMED